Segerdahl M - Search Results

1

Quantitative sensory testing using DFNS protocol in Europe: an evaluation of heterogeneity across multiple centers in patients with peripheral neuropathic pain and healthy subjects.

Vollert J, Attal N, Baron R, Freynhagen R, Haanpää M, Hansson P, Jensen TS, Rice ASC, Segerdahl M, Serra J, Sindrup SH, Tölle TR, Treede RD, Maier C. Vollert J, et al. Among authors: segerdahl m. Pain. 2016 Mar;157(3):750-758. doi: 10.1097/j.pain.0000000000000433. Pain. 2016. PMID: 26630440

2

Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain.

Belfrage M, Sollevi A, Segerdahl M, Sjölund KF, Hansson P. Belfrage M, et al. Among authors: segerdahl m. Anesth Analg. 1995 Oct;81(4):713-7. doi: 10.1097/00000539-199510000-00010. Anesth Analg. 1995. PMID: 7573999 Clinical Trial.

3

Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain.

Sollevi A, Belfrage M, Lundeberg T, Segerdahl M, Hansson P. Sollevi A, et al. Among authors: segerdahl m. Pain. 1995 Apr;61(1):155-158. doi: 10.1016/0304-3959(94)00187-J. Pain. 1995. PMID: 7644239

4

Intrathecal and systemic R-phenylisopropyl-adenosine reduces scratching behaviour in a rat mononeuropathy model.

Sjölund KF, Sollevi A, Segerdahl M, Hansson P, Lundeberg T. Sjölund KF, et al. Among authors: segerdahl m. Neuroreport. 1996 Jul 29;7(11):1856-60. doi: 10.1097/00001756-199607290-00034. Neuroreport. 1996. PMID: 8905680

5

Systemic adenosine infusion reduces the area of tactile allodynia in neuropathic pain following peripheral nerve injury: a multi-centre, placebo-controlled study.

Sjölund KF, Belfrage M, Karlsten R, Segerdahl M, Arnér S, Gordh T, Solevi A. Sjölund KF, et al. Among authors: segerdahl m. Eur J Pain. 2001;5(2):199-207. doi: 10.1053/eujp.2001.0237. Eur J Pain. 2001. PMID: 11465985 Clinical Trial.

6

Dose-dependent effects of morphine on experimentally induced cutaneous pain in healthy volunteers.

Schulte H, Sollevi A, Segerdahl M. Schulte H, et al. Among authors: segerdahl m. Pain. 2005 Aug;116(3):366-374. doi: 10.1016/j.pain.2005.05.005. Pain. 2005. PMID: 15982813 Clinical Trial.

7

Multiple dose gabapentin attenuates cutaneous pain and central sensitisation but not muscle pain in healthy volunteers.

Segerdahl M. Segerdahl M. Pain. 2006 Nov;125(1-2):158-64. doi: 10.1016/j.pain.2006.05.008. Epub 2006 Jun 14. Pain. 2006. PMID: 16781073 Clinical Trial.

8

Pain outcome variables--a never ending story?

Segerdahl M. Segerdahl M. Pain. 2011 May;152(5):961-962. doi: 10.1016/j.pain.2011.03.008. Pain. 2011. PMID: 21439731 No abstract available.

9

Understanding chronic inflammatory and neuropathic pain.

Hughes JP, Chessell I, Malamut R, Perkins M, Bačkonja M, Baron R, Farrar JT, Field MJ, Gereau RW, Gilron I, McMahon SB, Porreca F, Rappaport BA, Rice F, Richman LK, Segerdahl M, Seminowicz DA, Watkins LR, Waxman SG, Wiech K, Woolf C. Hughes JP, et al. Among authors: segerdahl m. Ann N Y Acad Sci. 2012 May;1255:30-44. doi: 10.1111/j.1749-6632.2012.06561.x. Ann N Y Acad Sci. 2012. PMID: 22564068

10

A pain model with a neuropathic somatosensory lesion: Morton neuroma.

Quiding H, Åkermark C, Segerdahl M, Reinholdsson I, Svensson H, Jonzon B. Quiding H, et al. Among authors: segerdahl m. Pain. 2013 Nov;154(11):2494-2499. doi: 10.1016/j.pain.2013.07.030. Epub 2013 Jul 23. Pain. 2013. PMID: 23886521 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page